TransMedics (TMDX) Net Cash Flow (2018 - 2026)

TransMedics has reported Net Cash Flow for 9 years, with the latest figure at $11.2 million in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 87.52% year-over-year to $11.2 million in Q2 2026; TTM through Jun 2026 was $90.5 million, a 144.91% increase from a year earlier, with the FY2025 full-year figure at $150.4 million, up 361.07% from the prior year.
• Net Cash Flow was $11.2 million for Q2 2026 at TransMedics, up from -$8.4 million in the prior quarter.
• The five-year high for Net Cash Flow was $386.8 million in Q2 2023, with the low at -$155.2 million in Q3 2023.
• Average Net Cash Flow over 5 years is $25.9 million, with a median of $1.8 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Cash Flow soared 6821.28% in 2022, then slumped 772.79% in 2023.
• Over 5 years, Net Cash Flow stood at -$3.7 million in 2022, then plunged by 772.79% to -$32.6 million in 2023, then surged by 122.22% to $7.2 million in 2024, then surged by 205.09% to $22.1 million in 2025, then plunged by 49.38% to $11.2 million in 2026.
• The last three Net Cash Flow figures came in at $11.2 million (Q2 2026), -$8.4 million (Q1 2026), and $22.1 million (Q4 2025), per Business Quant data.